Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3, reflecting a minor version bump in the underlying platform.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSite software revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedWebsite updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. These are administrative UI/text updates and do not alter study data or participation information.SummaryDifference0.4%

- Check87 days agoChange DetectedAdded a government funding lapse notice informing users that operations may be affected and directing them to cc.nih.gov for current updates; the NIH Clinical Center remains open. Footer revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.